131 related articles for article (PubMed ID: 31933778)
1. NDRG3 protein expression is associated with aggressive biologic phenotype and unfavorable outcome in patients with invasive breast cancer.
Kim MC; Park MH; Kang SH; Bae YK
Int J Clin Exp Pathol; 2019; 12(10):3886-3893. PubMed ID: 31933778
[TBL] [Abstract][Full Text] [Related]
2. Characterization of the prognostic values of the
Yu C; Hao X; Zhang S; Hu W; Li J; Sun J; Zheng M
Therap Adv Gastroenterol; 2019; 12():1756284819858507. PubMed ID: 31384305
[TBL] [Abstract][Full Text] [Related]
3. Prognostic impact of NDRG2 and NDRG3 in prostate cancer patients undergoing radical prostatectomy.
Ren GF; Tang L; Yang AQ; Jiang WW; Huang YM
Histol Histopathol; 2014 Apr; 29(4):535-42. PubMed ID: 24222185
[TBL] [Abstract][Full Text] [Related]
4. Characterization and expression of three novel differentiation-related genes belong to the human NDRG gene family.
Qu X; Zhai Y; Wei H; Zhang C; Xing G; Yu Y; He F
Mol Cell Biochem; 2002 Jan; 229(1-2):35-44. PubMed ID: 11936845
[TBL] [Abstract][Full Text] [Related]
5. Prognostic and biological role of the N-Myc downstream-regulated gene family in hepatocellular carcinoma.
Yin X; Yu H; He XK; Yan SX
World J Clin Cases; 2022 Mar; 10(7):2072-2086. PubMed ID: 35321174
[TBL] [Abstract][Full Text] [Related]
6. High expression of NDRG3 associates with positive lymph node metastasis and unfavourable overall survival in laryngeal squamous cell carcinoma.
Ma J; Liu S; Zhang W; Zhang F; Wang S; Wu L; Yan R; Wu L; Wang C; Zha Z; Sun J
Pathology; 2016 Dec; 48(7):691-696. PubMed ID: 27780595
[TBL] [Abstract][Full Text] [Related]
7. High expression of NDRG3 associates with unfavorable overall survival in non-small cell lung cancer.
Luo X; Hou N; Chen X; Xu Z; Xu J; Wang L; Yang S; Liu S; Xu L; Chen Y; Xiong L; Wang J; Fan W; Xu J
Cancer Biomark; 2018 Feb; 21(2):461-469. PubMed ID: 29171988
[TBL] [Abstract][Full Text] [Related]
8. NDRG3 is an androgen regulated and prostate enriched gene that promotes in vitro and in vivo prostate cancer cell growth.
Wang W; Li Y; Li Y; Hong A; Wang J; Lin B; Li R
Int J Cancer; 2009 Feb; 124(3):521-30. PubMed ID: 18975380
[TBL] [Abstract][Full Text] [Related]
9. Clinical significance of NDRG3 in patients with breast cancer.
Estiar MA; Zare AA; Esmaeili R; Farahmand L; Fazilaty H; Jafari D; Samadi T; Majidzadeh-A K
Future Oncol; 2017 May; 13(11):961-969. PubMed ID: 28326836
[TBL] [Abstract][Full Text] [Related]
10. NDRG1 Expression Is an Independent Prognostic Factor in Inflammatory Breast Cancer.
Villodre ES; Gong Y; Hu X; Huo L; Yoon EC; Ueno NT; Woodward WA; Tripathy D; Song J; Debeb BG
Cancers (Basel); 2020 Dec; 12(12):. PubMed ID: 33321961
[TBL] [Abstract][Full Text] [Related]
11. Differential expression patterns of NDRG family proteins in the central nervous system.
Okuda T; Kokame K; Miyata T
J Histochem Cytochem; 2008 Feb; 56(2):175-82. PubMed ID: 17998568
[TBL] [Abstract][Full Text] [Related]
12. High expression of NDRG3 correlates with poor prognosis in gastric cancer patients.
Liu Y; Xia J; Zhou Y; Shao S
Rev Esp Enferm Dig; 2021 Jul; 113(7):524-528. PubMed ID: 33562989
[TBL] [Abstract][Full Text] [Related]
13. NDRG3 overexpression is associated with a poor prognosis in patients with hepatocellular carcinoma.
Jing JS; Li H; Wang SC; Ma JM; Yu LQ; Zhou H
Biosci Rep; 2018 Dec; 38(6):. PubMed ID: 30413609
[TBL] [Abstract][Full Text] [Related]
14. Elevated Interleukin-13 Receptor Alpha 1 Expression in Tumor Cells Is Associated with Poor Prognosis in Patients with Invasive Breast Cancer.
Park MH; Kwon HJ; Kim JR; Lee B; Lee SJ; Bae YK
Ann Surg Oncol; 2017 Nov; 24(12):3780-3787. PubMed ID: 28634667
[TBL] [Abstract][Full Text] [Related]
15. Polycomb group protein EZH2 is frequently expressed in inflammatory breast cancer and is predictive of worse clinical outcome.
Gong Y; Huo L; Liu P; Sneige N; Sun X; Ueno NT; Lucci A; Buchholz TA; Valero V; Cristofanilli M
Cancer; 2011 Dec; 117(24):5476-84. PubMed ID: 21713757
[TBL] [Abstract][Full Text] [Related]
16. NDRGs in Breast Cancer: A Review and In Silico Analysis.
Villodre ES; Nguyen APN; Debeb BG
Cancers (Basel); 2024 Mar; 16(7):. PubMed ID: 38611020
[TBL] [Abstract][Full Text] [Related]
17. Interleukin-13 receptor alpha 2 expression in tumor cells is associated with reduced disease-free survival in patients with luminal subtype invasive breast cancer.
Kwon HJ; Choi JE; Bae YK
Tumour Biol; 2018 Jun; 40(6):1010428318783657. PubMed ID: 29911489
[TBL] [Abstract][Full Text] [Related]
18. NDRG3 and NDRG4, two novel tumor-related genes.
Yang X; An L; Li X
Biomed Pharmacother; 2013 Sep; 67(7):681-4. PubMed ID: 23725756
[TBL] [Abstract][Full Text] [Related]
19. Structural and Biophysical Analyses of Human N-Myc Downstream-Regulated Gene 3 (NDRG3) Protein.
Kim KR; Kim KA; Park JS; Jang JY; Choi Y; Lee HH; Lee DC; Park KC; Yeom YI; Kim HJ; Han BW
Biomolecules; 2020 Jan; 10(1):. PubMed ID: 31935861
[TBL] [Abstract][Full Text] [Related]
20. Prognostic significance of Bcl-2 in invasive mammary carcinomas: a comparative clinicopathologic study between "triple-negative" and non-"triple-negative" tumors.
Tawfik K; Kimler BF; Davis MK; Fan F; Tawfik O
Hum Pathol; 2012 Jan; 43(1):23-30. PubMed ID: 21777944
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
